Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Liquid Biopsy and Its Significance on the Early Detection of Breast Cancer; [بیوپسی مایع و اهمیت آن در تشخیص زودهنگام سرطان پستان] Publisher



Hasannejad F1 ; Fazilat A1 ; Majidzadeh KA1
Authors
Show Affiliations
Authors Affiliations
  1. 1. Department of Genetics, Breast Cancer Research Center, ACECR, Motamed Cancer Institute, Tehran, Iran

Source: Iranian Journal of Breast Diseases Published:2024


Abstract

Introduction: Liquid biopsy is a novel diagnostic tool that investigates biological biomarkers within the blood and other body liquids in order to provide information about the genetics of the tumor and its treatment response. The current review study aimed to highlight the role of liquid biopsy in breast cancer and precision medicine. Methods: In the current review study, we attempted to evaluate the recent innovations in breast cancer diagnosis by investigating liquid biopsy biomarkers in related databases, including Scopus, Web of Science, PubMed, and Google Scholar, from 2018 to 2024. Results: The assessment of the published articles in this field revealed that the applications of biomarkers in liquid biopsy have a significant role in personalized medicines, highlighting their reliability for use in personalized medicine. Conclusion: The liquid biopsy biomarkers seem to be a promising approach in breast cancer early detection and remarkable reduction of mortality caused by this disease in the near future. © 2024 Hasannejad et al.
Other Related Docs
23. Direct and Indirect Medical Costs of Bladder Cancer in Iran, Cost Effectiveness and Resource Allocation (2023)
30. Principles of Pharmacogenomics and Pharmacogenetics, Precision Medicine in Clinical Practice (2022)
39. Anti-Cd20 Antibody Treatment for B-Cell Malignancies, Resistance to Anti-CD20 Antibodies and approaches for their Reversal: Volume 2 (2023)
48. The Epidemiology of Brain and Spinal Cord Tumors, Advances in Experimental Medicine and Biology (2023)